The Pharmaceutical Pulse: A Year-End Reflection on Innovation, Politics, and Public Trust in 2025
The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies
The Unflinching Hand at the Helm: Richard Pazdur's Enduring Legacy at the FDA
A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative